Dysphagia

Dysphagia is difficulty swallowing — either a subjective sensation that food, liquid, or saliva is not moving normally from the mouth to the stomach, or an objectively demonstrable problem with any part of that process. It is not itself a diagnosis; it is a symptom that always points to an underlying anatomic, neurologic, motility, or medication-related problem and always deserves an explanation rather than being accepted as an inevitable part of aging.^[1]

Dysphagia is classified by where the problem occurs. Oropharyngeal dysphagia arises in the mouth and throat and typically presents with difficulty initiating a swallow, coughing or choking during or immediately after swallowing, drooling, a wet or gurgly voice change, repeated swallows needed to clear a mouthful, or nasal regurgitation of food or liquid.^[1][2] Esophageal dysphagia arises after the swallow has already been triggered and typically presents as a sensation of food sticking or getting stuck — usually described as retrosternal — several seconds after swallowing; solid food is affected before liquids in most structural causes, while both solids and liquids are affected from the outset in most motility disorders.^[1][2] Symptom localization by itself is an unreliable way to make this distinction — a patient who points to the throat or sternal notch may still have a problem lower down in the esophagus — so a careful history of timing and triggers matters more than where the patient points.^[2]

Speech-Language and Audiology Canada holds that speech-language pathologists take the primary role in evaluating and treating dysphagia of the oral, pharyngeal, and upper esophageal regions, working collaboratively across a patient's lifespan given how directly dysphagia affects health, nutrition, and quality of life.^[3] But dysphagia care is never a single-discipline problem, and pharmacists sit squarely inside it: patients with dysphagia are disproportionately dependent on oral medications, and every prescription written for them carries a second, often-overlooked question — can this particular formulation actually be swallowed safely by this particular patient? Getting that question wrong is not a minor inconvenience; it can dose-dump an extended-release opioid, destroy a delayed-release drug's protection, or send a poorly administered medication straight into the airway.

How common this actually is

Dysphagia is far more common than its reputation as "just part of getting older" suggests. It affects an estimated 55% of patients hospitalized with acute stroke, is expected to develop in nearly everyone with Parkinson's disease at some point in the disease course, and increases substantially with age and frailty.^[4][5] In Canada, an estimated 21,000 elderly patients develop new dysphagia after stroke every year.^[4]

Sagittal section of the mouth, pharynx, and larynx — the shared anatomy of the oral and pharyngeal swallowing phases that oropharyngeal dysphagia disrupts. (Henry Vandyke Carter, Gray's Anatomy of the Human Body, 1918; public domain, Wikimedia Commons)

Oropharyngeal dysphagia

Look for difficulty initiating a swallow, coughing or choking during or right after swallowing, a wet or "gurgly" voice quality after swallowing, drooling, needing multiple swallows to clear a single mouthful, and nasal regurgitation of food or liquid.^[1] These findings reflect impaired coordination or strength in the oral and pharyngeal phases of swallowing and put the patient at direct risk of aspiration — inhaling food, liquid, or secretions into the airway.^[3]

Esophageal dysphagia

Look for a sensation of food sticking or getting stuck several seconds after the swallow is initiated, usually localized retrosternally.^[1][2] A genuinely useful, though imperfect, teaching pattern: dysphagia for solids only that progresses over weeks to months points toward a structural narrowing (stricture, ring, tumour); dysphagia for solids and liquids together, present from the outset, points toward a motility disorder (achalasia, diffuse esophageal spasm, scleroderma-related hypomotility).^[2]

Aspiration pneumonia — the central downstream risk

Aspiration pneumonia is the consequence that ties nutrition, hydration, and medication administration together in dysphagia care. After stroke, dysphagia carries a 3-fold increased risk of aspiration pneumonia, rising to an 11-fold increased risk in patients with aspiration confirmed on videofluoroscopy — and silent aspiration, with no visible cough or choking at all, occurs in up to two-thirds of post-stroke patients with dysphagia.^[4] This is exactly why "the patient didn't cough" is not reassurance that a swallow, or a medication given orally, was actually safe.

Neurologic causes (the leading cause of oropharyngeal dysphagia)

• Stroke — the single most common cause of oropharyngeal dysphagia, affecting an estimated 55% of patients with acute stroke.^[4]
• Parkinson's disease — swallowing changes can occur at any point in the disease course and tend to increase as the disease progresses; aspiration pneumonia is the leading cause of death in Parkinson's disease.^[5]
• Amyotrophic lateral sclerosis (ALS) and other motor neuron disease — progressive bulbar weakness produces a predictable decline in swallowing safety over the disease course.
• Dementia (Alzheimer's, vascular, and other subtypes) — cognitive impairment and the motor aspects of swallowing are both affected; co-occurring language or cognitive impairment further increases aspiration risk.^[3]
• Multiple sclerosis, myasthenia gravis, and other neuromuscular disease affecting bulbar muscles.
• Traumatic brain injury, and surgery or radiation therapy for head and neck cancer.

Structural causes (typically solids-predominant, progressive)

• Esophageal stricture — peptic (from chronic reflux), radiation-induced, or caustic.
• Esophageal rings and webs (for example, a Schatzki ring).
• Esophageal or head-and-neck malignancy — always part of the differential for progressive dysphagia with weight loss.
• Zenker diverticulum — an outpouching between the thyropharyngeus and cricopharyngeus muscles from incomplete upper esophageal sphincter opening, presenting with dysphagia, regurgitation of undigested food, and halitosis.
• Eosinophilic esophagitis (EoE) — eosinophilic mucosal infiltration causing luminal narrowing, wall stiffness, and fibrosis; food impaction is a common presentation, and patients often develop unconscious adaptive behaviours — cutting food into small pieces, excessive chewing, prolonged mealtimes, avoiding hard textures, and turning away tablets or pills — long before they volunteer "dysphagia" as a symptom.^[6]

Lateral esophagram showing a Zenker diverticulum — a structural cause of esophageal dysphagia presenting with regurgitation of undigested food. (James Heilman, MD, CC BY-SA 4.0, Wikimedia Commons)

Motility disorders (solids and liquids together, from the outset)

• Achalasia — failure of lower esophageal sphincter relaxation with loss of organized peristalsis; presents with dysphagia for solids and liquids in roughly 90% of patients, regurgitation in about 75%, weight loss in about 60%, chest pain in about 50%, and heartburn in about 40%.^[7]
• Diffuse esophageal spasm and other spastic motility disorders.
• Systemic sclerosis (scleroderma) — smooth muscle atrophy and fibrosis produce progressive esophageal hypomotility.

Medication-related causes — genuinely pharmacist territory

• Anticholinergic drugs (oxybutynin, diphenhydramine, tricyclic antidepressants, benztropine, and others) reduce salivary flow; the resulting dry mouth impairs bolus formation and lubrication and can meaningfully worsen an existing swallowing problem.
• Sedating drugs (benzodiazepines, opioids, sedating antihistamines) blunt the cough and gag reflex and reduce the alertness needed to swallow safely, increasing aspiration risk independent of any structural or neurologic cause.
• Dopamine-antagonist drugs (metoclopramide, and some antipsychotics) can cause extrapyramidal symptoms that directly worsen swallowing coordination — a particular hazard when a patient's dysphagia already has a parkinsonian cause.
• Doxycycline and other tetracyclines, bisphosphonates (alendronic acid, risedronate), NSAIDs, potassium chloride, and iron salts are the medications most often implicated in pill-induced esophagitis, which can itself produce odynophagia and a new sensation of dysphagia — see Choose Initial Treatment and Drug Tables.^[8]

Age and frailty

• Presbyphagia — the age-related decline in swallowing muscle mass, strength, and reserve — lowers the threshold at which any additional insult (illness, sedation, a new medication) tips a previously safe swallow into an unsafe one.
• Frailty and polypharmacy are each independently associated with dysphagia, and the two compound each other.
• Poor dentition or edentulism impairs the oral preparatory phase directly.

History: the single most useful diagnostic tool

Establish onset (acute versus progressive), what specifically triggers symptoms (solids only versus solids and liquids together, from the outset or delayed), and associated features — coughing, choking, or nasal regurgitation point oropharyngeal; heartburn, regurgitation, or chest pain point esophageal.^[1][2] Screen specifically for the alarm features that change the pathway directly to endoscopy — age 50 or older, gastrointestinal bleeding, unintentional weight loss, recurrent vomiting, and odynophagia.^[2] A complete medication history and a genuine medication review are not an afterthought here; they are diagnostic, since a new anticholinergic, sedative, or dopamine-antagonist drug can be the reason dysphagia appeared or worsened in the first place.

Bedside swallow screening — before any oral intake, including medications

A validated bedside swallow screen should be completed before any oral intake — food, liquid, or medication — particularly after acute stroke, and can be performed by any appropriately trained healthcare professional, not only a speech-language pathologist.^[9] The Toronto Bedside Swallowing Screening Test (TOR-BSST), developed and validated in Canadian stroke patients, takes under 10 minutes to administer and correctly identified dysphagia with a sensitivity of 91.3% and a negative predictive value of 93.3% in acute care in its validation study.^[10] Dysphagia screening itself, not just downstream management, measurably reduces the odds of pneumonia.^[9] Anyone who fails a bedside screen needs referral to a trained dysphagia professional — typically a speech-language pathologist — for a comprehensive assessment before oral intake resumes.^[9]

Instrumental assessment

The videofluoroscopic swallowing study (VFSS), also called the modified barium swallow study, is the reference-standard instrumental test for oropharyngeal dysphagia: it provides a real-time, dynamic radiographic view of the oral, pharyngeal, and upper esophageal phases of swallowing across different food and liquid textures, and can identify the presence, timing, and cause of aspiration — including silent aspiration that a bedside screen alone would miss.^[4] Fibreoptic endoscopic evaluation of swallowing (FEES) is a complementary instrumental option that avoids radiation exposure. Both are ordered and interpreted in collaboration with speech-language pathology, not independently by the referring prescriber.

The esophageal dysphagia diagnostic pathway

For esophageal dysphagia specifically, the Canadian Association of Gastroenterology recommends a staged approach.^[2] In a patient younger than 50 with reflux-type symptoms and no alarm features, a 4-week empiric proton pump inhibitor trial is reasonable, with further testing recommended if dysphagia does not fully resolve — the trial is not meant to be extended or repeated indefinitely.^[2] Everyone else — anyone with an alarm feature, age 50 or older, or dysphagia that does not fully resolve on an empiric trial — should proceed to endoscopy as the initial test, since it offers the highest diagnostic yield for structural and inflammatory causes.^[2] Esophageal biopsy is recommended at that same endoscopy in essentially every patient, even without visible erosive esophagitis, specifically to avoid missing eosinophilic esophagitis.^[2] If endoscopy and biopsy do not explain the dysphagia, esophageal manometry — ideally high-resolution manometry — is the next step to evaluate for a motility disorder such as achalasia.^[2] A barium esophagram is a reasonable substitute when endoscopy access is limited locally, to assess for a significant structural lesion and support timely referral.^[2]

• Confirm dysphagia is present, classify it as oropharyngeal or esophageal, and identify the underlying cause — dysphagia is a symptom, not a final diagnosis.
• Protect the airway and prevent aspiration pneumonia — the consequence that ties every other goal in this list together.
• Maintain adequate nutrition and hydration through a route and texture that is genuinely safe for this specific patient.
• Treat or manage the underlying cause where one is treatable (reflux, eosinophilic esophagitis, a stricture, achalasia).
• Make certain every medication this patient takes can genuinely be swallowed safely — reviewing formulation appropriateness is not a peripheral add-on to dysphagia care, it is one of its core, ongoing tasks.
• Avoid the opposite failure mode too: do not withhold or omit clinically important medications (analgesics, antiepileptics, cardiac drugs) out of an overcautious "nothing by mouth" reflex when a safe route of administration is achievable.
• Preserve dignity, comfort, and quality of life around eating and drinking, not just physiological safety.
• Educate the patient, family, and caregivers on safe swallowing technique and safe medication administration technique together, as one conversation rather than two.

Why some formulations must never be crushed, split, or chewed

Extended, sustained, or controlled-release these formulations are engineered — through a matrix, membrane, or osmotic-pump mechanism — to release drug gradually over many hours. Crushing destroys that mechanism and releases the entire intended multi-hour dose at once. A real Canadian case example: a sustained-release oxycodone tablet, designed to deliver its dose over 12 hours, was crushed for administration — the patient absorbed the full 12-hour dose immediately and developed sedation and respiratory depression.^[11] The same dose-dumping risk applies to any extended-release opioid, cardiac drug, or antidepressant.

Enteric-coated the coating exists either to protect the drug from being inactivated by stomach acid, or to protect the stomach lining from the drug itself. Crushing an enteric-coated tablet — for example, a proton pump inhibitor formulated for acid protection — destroys the coating and can inactivate the drug before it is absorbed.^[11] Some enteric-coated products are capsules containing coated granules or pellets rather than a coated tablet; the capsule shell itself may be labelled to be opened, with the granules sprinkled — never chewed or crushed — onto a small amount of soft, acidic food, but this is a specific, product-labelled exception, not a general licence to crush any enteric-coated product. Confirm the exact technique against the product monograph or the pharmacist, every time.

Sublingual or buccal these tablets are designed to dissolve against the oral mucosa for rapid absorption directly into the bloodstream, bypassing first-pass hepatic metabolism entirely. Crushing a sublingual tablet and having the patient swallow it — rather than letting it dissolve under the tongue — sends the drug through an entirely different pharmacokinetic pathway and can blunt or delay the fast onset the formulation exists to provide, for example with sublingual nitroglycerin during angina.

Safer alternatives to reach for before crushing anything

Thickened liquids and the IDDSI framework — liquid medications are not automatically safe

Many patients with oropharyngeal dysphagia are prescribed thickened fluids under the International Dysphagia Diet Standardisation Initiative (IDDSI) framework — a globally adopted, standardized 8-level continuum (Levels 0-4 describing drink thickness, Levels 3-7 describing food texture) used to make sure everyone on the care team, and the patient's own kitchen or pharmacy, means exactly the same thing by "thin," "nectar-thick," or "pudding-thick."^[12] The clinician's own comprehensive assessment — not a generic label — determines which specific level is safe for an individual patient, and altering the framework's own definitions is specifically discouraged because it reintroduces the confusion IDDSI exists to remove.^[12]

The genuinely easy-to-miss pharmacist point: a liquid medication is not automatically "dysphagia-safe" just because it is not a tablet. If a patient is prescribed thickened fluids at a specific IDDSI level, their oral liquid medications need to match that same level of thickness — an unmodified thin oral solution or suspension can be aspirated exactly like an unmodified glass of water. Confirm with the speech-language pathologist or dietitian before assuming a liquid formulation solves the problem on its own, and be aware that thickening a liquid drug product yourself, off-label, can change its bioavailability — this is a decision made with the full team, not unilaterally at the bedside.

Preventing pill-induced esophagitis in patients who can safely swallow tablets

For patients whose swallow is otherwise safe for solids, counsel specifically on the medications most often implicated in pill-induced esophagitis — doxycycline and other tetracyclines, bisphosphonates, NSAIDs, potassium chloride, and iron salts.^[8] Take these with a full glass of water (at least 200 to 250 mL) while upright, avoid lying down for at least 30 minutes afterward, and — for oral bisphosphonates specifically — remain upright until the first food or drink of the day.^[8] Insufficient water and a recumbent position are the two behavioural risk factors that show up again and again in pill-induced esophagitis.^[8]

When crushing genuinely is appropriate

For a true immediate-release, non-enteric-coated tablet, or a capsule whose contents are not coated pellets, crushing can be reasonable once the questions above have been answered — but technique still matters. Crush to a fine, lump-free powder; mix with a small amount of an appropriate texture (matched to the patient's own dysphagia plan, not just whatever is on hand); and give one medication at a time rather than batching several crushed drugs into a single spoonful, since batching increases the risk of residue being left behind, of an interaction in the mixing vehicle, and of an inaccurate total dose actually reaching the patient.^[11] In real practice, a meaningful share of medications that end up being crushed or opened at the bedside were never actually authorized by a prescriber or pharmacist, and the crushing itself is frequently avoidable simply by switching to a more suitable existing formulation — the fix is usually a formulation review, not better crushing technique.

Build this into the system, not just into one conversation

The most durable fix is institutional, not a single bedside reminder: maintain an up-to-date, readily accessible list of medications that must not be crushed with their suggested alternatives, and build computerized decision support that flags a prohibited crush or an inappropriate route before the error reaches the patient.^[11] The pharmacist is the natural point of contact for exactly this kind of formulation-change decision, and should be looped in proactively whenever a dysphagia diagnosis is documented — not only after a crushing error has already happened.

• Speech-language pathology-directed compensatory strategies — chin tuck, head turn toward the weaker side, effortful swallow, and the supraglottic swallow manoeuvre — can make an otherwise unsafe swallow safe without changing diet or medication at all.
• Upright positioning during meals and medication administration, and for at least 30 minutes afterward, reduces both aspiration risk and pill-induced esophagitis risk.^[8]
• Texture-modified diets and thickened liquids, prescribed to a specific IDDSI level by the speech-language pathologist or dietitian, remain a core intervention — but they are not automatically benign: liquids that are less palatable when thickened are consumed less, and under-consumption can itself cause dehydration, so adherence needs to be actively monitored, not assumed.^[12]
• Swallowing rehabilitation exercises, directed by speech-language pathology, can genuinely strengthen and restore function over time in appropriate candidates, rather than only compensating around a fixed deficit.
• Meticulous oral care and dental hygiene reduce the bacterial load of any material that is aspirated, lowering pneumonia risk even in a patient whose aspiration itself cannot be fully eliminated.^[9]
• Encourage self-feeding wherever the patient is able, rather than defaulting to being fed — self-feeding is specifically associated with a reduced risk of aspiration pneumonia.^[9]
• Dietitian involvement for ongoing nutritional adequacy is essential alongside — not instead of — swallowing safety measures.
• Enteral feeding (nasogastric or gastrostomy) is appropriate when oral intake cannot be made safe or sufficient; in ALS specifically, gastrostomy placement is generally recommended once weight loss reaches about 10% of body weight and/or before forced vital capacity falls below 50% of predicted, and the conversation should start well before either threshold is reached, not after a crisis.
• Deprescribing is itself a non-pharmacologic intervention here: reviewing the medication list for anticholinergic burden, unnecessary sedatives, and dopamine-antagonist drugs that worsen swallowing is as much a part of dysphagia management as any swallowing exercise.
• Use a genuinely multidisciplinary team — speech-language pathology, dietitian, pharmacist, physician, and nursing — and treat medication administration safety as something assessed alongside food and fluid safety from the start, not bolted on afterward.^[3]

Post-stroke dysphagia

Screen every stroke patient for swallowing impairment before any oral intake — food, liquid, or medication — ideally using a validated tool such as the TOR-BSST, which takes under 10 minutes and was developed and validated specifically in Canadian stroke patients.^[10][9] Dysphagia affects an estimated 55% of patients with acute stroke, carries a 3-fold increased risk of aspiration pneumonia (11-fold with confirmed aspiration on videofluoroscopy), and up to two-thirds of affected patients aspirate silently, without any visible cough or choking.^[4] Refer anyone who fails the screen to speech-language pathology for a comprehensive assessment before oral intake resumes.^[9]

Parkinson's disease

Nearly everyone with Parkinson's disease develops some degree of swallowing difficulty at some point in the disease course, and aspiration pneumonia is the leading cause of death in Parkinson's disease.^[5] Avoid or use extreme caution with dopamine-antagonist drugs — metoclopramide and some antipsychotics — since these can produce extrapyramidal symptoms that directly worsen the same swallowing coordination problem being managed; anticholinergic drugs used for tremor (for example, benztropine) independently worsen dry mouth and can compound dysphagia at the same time. As swallowing changes progress, discuss switching maintenance medications to a transdermal option (such as a rotigotine patch) proactively, before a crisis forces the decision.

Amyotrophic lateral sclerosis and other progressive neuromuscular disease

Dysphagia here is predictably progressive. Involve speech-language pathology and dietitian input early, well before a swallowing crisis. Gastrostomy is generally recommended once weight loss reaches roughly 10% of body weight and/or before forced vital capacity falls below 50% of predicted, and the conversation about it should start before either threshold is reached.

Dementia

Aspiration risk is high, and co-occurring language and cognitive impairment further increase it.^[3] Every medication review is also an opportunity to reduce overall pill burden and anticholinergic load, both of which independently worsen dysphagia. Decisions about comfort-focused feeding versus continued or enteral feeding at an advanced stage are individualized, values-based, and made with the patient's substitute decision-maker and full care team — not a default determined by dysphagia severity alone.

Eosinophilic esophagitis

Confirm on biopsy at endoscopy, which is obtained routinely during the esophageal dysphagia workup even without visible erosive changes.^[2] Watch for the adaptive behaviours patients normalize long before naming dysphagia as a symptom: cutting food small, excessive chewing, prolonged mealtimes, avoiding hard textures, and turning away tablets or pills.^[6] Swallowed topical corticosteroid therapy (viscous budesonide or swallowed fluticasone) is first-line maintenance treatment once confirmed — see Drug Tables.^[6]

Older adults and frailty

Presbyphagia lowers the safety margin before any additional insult — a new sedating drug, an acute illness — tips a previously safe swallow into an unsafe one. Frailty and polypharmacy are each independently associated with dysphagia and compound each other; a proactive medication review specifically for anticholinergic burden, sedative load, unnecessarily large tablets, and genuinely necessary versus discretionary drugs belongs in every comprehensive geriatric assessment.

Renal and hepatic impairment

No dose adjustment is required for proton pump inhibitors or swallowed topical budesonide in renal impairment; use budesonide cautiously in significant hepatic impairment given reduced first-pass clearance. Adjust any analgesic or other maintenance medication in the usual way for the patient's organ function — dysphagia itself does not change those thresholds.

Pediatrics

Pediatric dysphagia — including feeding difficulty in prematurity and pediatric eosinophilic esophagitis — is managed with materially different diagnostic thresholds and a pediatric speech-language pathology and gastroenterology team; this chapter's diagnostic and medication-administration framework is written for adult patients and should not be applied unmodified to children.

Reassess swallowing status on a schedule that matches the underlying cause rather than only once: status can genuinely improve over days to weeks after an acute stroke, and it predictably declines over time in Parkinson's disease, ALS, and other progressive neurologic disease — a plan that was safe six months ago may not be safe today.^[5]

• Track nutritional status and weight trend with the dietitian; unexplained weight loss in a patient already carrying a dysphagia diagnosis still deserves the same scrutiny as new-onset weight loss.
• Monitor hydration adequacy specifically in patients on thickened liquids — reduced palatability can lead to under-consumption and dehydration even when the texture modification itself is working exactly as intended.^[12]
• Treat any new episode of aspiration pneumonia as a sentinel event that requires reassessing the entire swallowing and medication-administration plan, not simply treating the pneumonia and resuming the same plan unchanged.
• At every medication review, specifically re-confirm that any crushed, opened, or reformulated medication on the list is still being prepared and given correctly, and that a switch away from an extended-release product has actually been reconciled to an equivalent total daily dose — this is exactly the kind of detail that drifts silently across multiple prescriber and pharmacy handoffs.
• For eosinophilic esophagitis on swallowed topical corticosteroid therapy, follow the same surveillance-biopsy approach used to confirm histologic remission, per gastroenterology.^[6]
• For achalasia managed with botulinum toxin injection or pharmacotherapy, remember the effect is genuinely time-limited — reassess symptom control on a defined schedule rather than waiting for the patient to report recurrence.^[7]

1. Bedside swallow screen fails, or symptoms persist despite compensatory strategies: escalate to a formal speech-language pathology assessment, with videofluoroscopy or FEES as indicated, rather than continuing empiric texture modification alone.^[9]
2. Esophageal dysphagia with reflux-type symptoms not fully resolved after a 4-week empiric proton pump inhibitor trial: proceed to endoscopy — do not simply repeat or extend the empiric trial.^[2]
3. Eosinophilic esophagitis confirmed but dysphagia persists on swallowed topical corticosteroid therapy: reassess adherence and technique first (the slurry vehicle, the required post-dose fasting period) before assuming the drug itself has failed, and involve gastroenterology for dose escalation or biopsy-confirmed reassessment.^[6]
4. Achalasia treated with pharmacotherapy or botulinum toxin injection with recurrent symptoms: escalate to pneumatic dilation, peroral endoscopic myotomy, or Heller myotomy rather than repeating medical therapy indefinitely — durability of the medical options is genuinely limited, typically months.^[7]
5. Recurrent aspiration despite texture modification and compensatory strategies that were previously judged adequate: reassess the need for enteral feeding with the full team rather than assuming stricter adherence to the existing plan will fix it.
6. A specific medication keeps being crushed or administered unsafely despite counseling: treat this as a medication-list and system problem — a full reconciliation looking for consolidation, alternative-formulation swaps, or deprescribing opportunities — rather than repeating the same instruction to the same caregiver.^[11]
7. Any new or worsening neurologic sign appearing alongside dysphagia at any point in follow-up: stop, re-screen, and escalate for urgent neurologic assessment rather than assuming it is part of a known, stable diagnosis.

• Crushing an extended-release, sustained-release, or osmotic-pump tablet because it seems easier, without checking the formulation first.^[11]
• Opening an enteric-coated capsule and crushing the coated granules inside it, destroying the exact protection the coating exists to provide.^[11]
• Crushing a sublingual or buccal tablet and having the patient swallow it, rather than letting it dissolve against the oral mucosa as intended.
• Cutting, cracking, or otherwise damaging a fentanyl or buprenorphine patch to try to adjust the dose — a distinct and serious overdose hazard from oral tablet-crushing errors.
• Batching several crushed medications together in a single spoonful "to save time," rather than administering them one at a time.^[11]
• Assuming a liquid medication is automatically safe for a patient on thickened fluids without checking or adjusting it to their prescribed IDDSI level.^[12]
• Relying on where the patient points, or how they describe the sensation, to reliably distinguish oropharyngeal from esophageal dysphagia — symptom localization is specifically unreliable.^[2]
• Treating globus (a persistent throat-lump sensation unrelated to swallowing) as true dysphagia and pursuing an unnecessary endoscopic workup.^[2]
• Continuing to offer food, liquid, or oral medication to a post-stroke patient before a validated swallow screen has been completed.^[9]
• Reaching for metoclopramide or another dopamine-antagonist drug in a patient with Parkinson's-related or other parkinsonian dysphagia without recognizing the extrapyramidal risk.
• Assuming thickened liquids are automatically risk-free — reduced palatability can cause under-consumption and dehydration even when the texture modification itself is appropriate.^[12]
• Attributing progressive dysphagia with weight loss to normal aging rather than pursuing it as a possible malignancy.^[2]

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Formulations That Must Never Be Crushed, Split, or Chewed

Confirm this list against the product monograph or the pharmacist before any dose is administered — this is illustrative, not exhaustive.

Safer Alternative Formulations to Reach for Before Crushing

Switching to one of these, where clinically appropriate, is usually a better first move than crushing the standard tablet.

Medications That Commonly Cause Pill-Induced Esophagitis — Counsel on Water and Positioning

Take with a full glass of water (at least 200 to 250 mL) while upright, and remain upright for at least 30 minutes afterward; insufficient water and lying down soon after are the two behavioural risk factors that show up again and again.

Pharmacologic Management of Underlying or Contributing Causes

Treats the cause behind the dysphagia, not the swallowing mechanics themselves — always paired with the swallowing-safety and formulation measures above.

Medications That Commonly Worsen Dysphagia via Xerostomia, Sedation, or Extrapyramidal Effects — Review for Deprescribing

None of these are contraindicated outright, but each is worth a specific second look whenever dysphagia is new, worsening, or hard to control.